Cargando…
Biosimilars in Oncology: Latest Trends and Regulatory Status
Biologic-based medicines are used to treat a variety of diseases and account for around one-quarter of the worldwide pharmaceutical market. The use of biologic medications among cancer patients has resulted in substantial advancements in cancer treatment and supportive care. Biosimilar medications (...
Autores principales: | Joshi, Deeksha, Khursheed, Rubiya, Gupta, Saurabh, Wadhwa, Diksha, Singh, Thakur Gurjeet, Sharma, Sumit, Porwal, Sejal, Gauniyal, Swati, Vishwas, Sukriti, Goyal, Sanjay, Gupta, Gaurav, Eri, Rajaraman D., Williams, Kylie A., Dua, Kamal, Singh, Sachin Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784530/ https://www.ncbi.nlm.nih.gov/pubmed/36559215 http://dx.doi.org/10.3390/pharmaceutics14122721 |
Ejemplares similares
-
Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations
por: Vishwas, Sukriti, et al.
Publicado: (2021) -
Gut Dysbiosis and Diabetic Foot Ulcer: Role of Probiotics
por: Awasthi, Ankit, et al.
Publicado: (2022) -
A global comparison of implementation and effectiveness of materiovigilance program: overview of regulations
por: Joshi, Deeksha, et al.
Publicado: (2021) -
Recent Progress in Development of Dressings Used for Diabetic Wounds with Special Emphasis on Scaffolds
por: Awasthi, Ankit, et al.
Publicado: (2022) -
OUTBREAK of novel corona virus disease (COVID-19): Antecedence and aftermath
por: Awasthi, Ankit, et al.
Publicado: (2020)